Infinata’s BioPharm Insight Signs 200th Media Partner, Inaugurates Advertising Program

Biopharmaceutical industry organizations sign up to raise visibility and attendance at key events

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Media partners and advertisers rely on BioPharm Insight to develop awareness and reach the most influential decision makers in the biopharma industry.

Norwood, MA (PRWEB) February 14, 2013

Infinata’s BioPharm Insight™ announced it signed its 200th media partner and unveiled an advertising program designed to help partners increase attendance at their events. BioPharm Insight offers the global biopharmaceutical community a unique combination of business intelligence, market analytics, key industry contacts, and award-winning independent investigative journalism.

Infinata partners with businesses and organizations within all biopharma and wealth sectors to promote industry-changing events such as conferences and symposia. Media partners include:

  •     Biotechnology Industry Organization (BIO)
  •     Drug Information Association (DIA)
  •     The Conference Forum
  •     EBD Group
  •     SMi Group
  •     HealthNetwork Communications
  •     Worldwide Business Research (WBR)
  •     Partnerships in Clinical Trials
  •     The Financial Times
  •     ExL Pharma
BioPharm Insight Inaugurates Advertising Program

Industry professionals rely on BioPharm Insight’s newsletter program to stay ahead of their competition with updates on proprietary forward-looking intelligence, clinical trial news, and upcoming industry conferences. BioPharm Insight has created a new opportunity to get in front of these influential executives with a completely redesigned newsletter providing optimal space for companies to promote their solutions.

Jim Davis, Infinata’s Global Head of Sales for its BioPharm Suite, said, “Media partners and advertisers rely on BioPharm Insight to develop awareness and reach the most influential decision makers in the biopharma industry.”

To learn more about becoming a BioPharm Insight Media Partner or to take advantage of the new Advertising Program, please contact Holly Burke at hburke(at)infinata(dot)com or 781-619-0131.

Learn how BioPharm Insight can help you find new business opportunities by starting a free trial today.

About BioPharm Insight
BioPharm Insight is the definitive guide to the global biopharma community. BioPharm Insight provides subscribers with an information edge by combining the most comprehensive real-time database of companies, drugs, contacts, M&A and licensing deals, forecasts and clinical trial data with proprietary forward-looking intelligence uncovered by an independent team of investigative journalists months or even years before it breaks in mainstream media. To learn more, visit http://www.biopharminsight.com. Follow BioPharm Insight on LinkedIn and Twitter.

About Infinata, Inc.
Infinata provides personalized technology solutions to turn information into insight. Services include a comprehensive BioPharm Solutions Suite, unique Wealth Prospecting tools and innovative Custom Data Services. Infinata is a part of Mergermarket, a Financial Times Group company and a division of Pearson plc. To learn more, visit http://www.infinata.com.


Contact

Follow us on: Contact's Twitter Contact's LinkedIn